Availability of body art facilities and body art piercing do not predict hepatitis C acquisition among injection drug users in Montreal, Canada: Results from a cohort study

International Journal of Drug Policy

Volumn 21, Issue 6, 2010, Pages 477-484

  Bruneau, Julie ^a,b   Daniel, Mark ^a,b,c   Kestens, Yan ^a,b   Abrahamowicz, Michal ^d   Zang, Geng ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Body piercing; Epidemiology; HCV; Incidence; Injection drug use

Indexed keywords

ADULT; ARTICLE; BODY PIERCING; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL MODEL;

ADULT; BODY PIERCING; COHORT STUDIES; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; QUEBEC; RESIDENCE CHARACTERISTICS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION;

EID: 78649326613     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.05.001     Document Type: Article

References (48)

1. Alter H.J., Conry-Cantilena C., Melpolder J., Tan D., Van Raden M., Herion D., et al. Hepatitis C in asymptomatic blood donors. Hepatology 1997, 26(3 Suppl. 1):29S-33S.
2. Armstrong M.L. Tattooing, body piercing, and permanent cosmetics: A historical and current view of state regulations, with continuing concerns. Journal of Environmental Health 2005, 67(8):38-43. 54, 53.
3. Armstrong M.L., Koch J.R., Saunders J.C., Roberts A.E., Owen D.C. The hole picture: Risks, decision making, purpose, regulations, and the future of body piercing. Clinical Dermatology 2007, 25(4):398-406.
4. Backmund M., Meyer K., Wachtler M., Eichenlaub D. Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity. European Journal of Epidemiology 2003, 18(6):563-568.
5. Baldo V., Baldovin T., Trivello R., Floreani A. Epidemiology of HCV infection. Current Pharmaceutical Design 2008, 14(17):1646-1654.
6. Bone A., Ncube F., Nichols T., Noah N.D. Body piercing in England: A survey of piercing at sites other than earlobe. BMJ 2008, 336(7658):1426-1428.
7. Briggs M.E., Baker C., Hall R., Gaziano J.M., Gagnon D., Bzowej N., et al. Prevalence and risk factors for hepatitis C virus infection at an urban veterans administration medical center. Hepatology 2001, 34(6):1200-1205.
8. Brogly S.B., Bruneau J., Lamothe F., Vincelette J., Franco E.L. HIV-positive notification and behavior changes in Montreal injection drug users. AIDS Education and Prevention 2002, 14(1):17-28.
9. Bruneau J., Lamothe F., Soto J., Lachance N., Vincelette J., Vassal A., et al. Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal 2001, 164(6):767-773.
10. Bruneau J., Daniel M., Kestens Y., Zang G., Genereux M. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes. Journal of Epidemiology and Community Health 2008, 62(9):804-810.
11. Comité permanent de lutte à la toxicomanie.Ministère de la santé et des services sociaux Le point sur la situation de la toxicomanie au Québec en l'an 2000. Ministère de la santé et des services sociaux 2000, Gouvernement du Québec, Retrieved 25.01.09.
12. Cooper H., Moore L., Gruskin S., Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Social Science & Medicine 2005, 61(3):673-684.
13. Cooper H.L., Bossak B., Tempalski B., Des Jarlais D.C., Friedman S.R. Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy 2009, 20:217-226.
14. Daniel M., Kestens Y. Geographic information system: MEGAPHONE - Montreal epidemiological and geographic analysis of population health outcomes and neighbourhood effects 2007, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Canada, ® 1046898.
15. Daniel M., Kestens Y., Paquet C. Demographic and urban form correlates of healthful and unhealthful food availability in Montreal, Canada. Canadian Journal of Public Health 2009, 100(3):189-193.
16. De P., Cox J., Boivin J.F., Platt R.W., Jolly A.M., Alexander P.E. HIV and HCV discordant injecting partners and their association to drug equipment sharing. Scandinavian Journal of Infectious Diseases 2009, 41(3):206-214.
17. Dolan K.A., Wodak A.D., Hall W.D. A bleach program for inmates in NSW: An HIV prevention strategy. Australian and New Zealand Journal of Public Health 1998, 22(7):838-840.
18. Falster K., Kaldor J.M., Maher L. Hepatitis C virus acquisition among injecting drug users: A cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. Journal of Urban Health 2009, 86(1):106-118.
19. Flanders W.D., Klein M. Properties of 2 counterfactual effect definitions of a point exposure. Epidemiology 2007, 18(4):453-460.
20. Friedman S.R., Cooper H.L., Tempalski B., Keem M., Friedman R., Flom P.L., et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS 2006, 20(1):93-99.
21. Galea S., Ahern J., Vlahov D., Coffin P.O., Fuller C., Leon A.C., et al. Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug and Alcohol Dependence 2003, 70(2):139-148.
22. Genereux M., Bruneau J., Daniel M. Association between neighbourhood socioeconomic characteristics and high-risk injection behaviour amongst injection drug users living in inner and other city areas in Montreal, Canada. International Journal of Drug Policy 2010, 21(1):49-55.
23. Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001, 91(1):42-46.
24. Haley R.W., Fischer R.P. The tattooing paradox: Are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection?. Archives of Internal Medicine 2003, 163(9):1095-1098.
25. Hayes M.O., Harkness G.A. Body piercing as a risk factor for viral hepatitis: An integrative research review. American Journal of Infection Control 2001, 29(4):271-274.
26. Hellard M.E., Hocking J.S., Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiology and Infection 2004, 132(3):409-415.
27. Hernan M.A., Hernandez-Diaz S., Robins J.M. A structural approach to selection bias. Epidemiology 2004, 15(5):615-625.
28. Holsen D.S., Harthug S., Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12(9):673-676.
29. Hutchinson S.J., Taylor A., Goldberg D.J., Gruer L. Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: Implications for control and prevention of blood-borne viruses. Addiction 2000, 95(6):931-940.
30. Kazandjieva J., Tsankov N. Tattoos: Dermatological complications. Clinical Dermatology 2007, 25(4):375-382.
31. Latkin C.A., Williams C.T., Wang J., Curry A.D. Neighborhood social disorder as a determinant of drug injection behaviors: A structural equation modeling approach. Health Psychology 2005, 24(1):96-100.
32. Laumann A.E., Derick A.J. Tattoos and body piercings in the United States: A national data set. Journal of the American Academy of Dermatology 2006, 55(3):413-421.
33. Luksamijarulkul P., Deangbubpha A. Hepatitis C antibody prevalence and risk factors of some female sex workers in Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health 1997, 28(3):507-512.
34. Maas B., Fairbairn N., Kerr T., Li K., Montaner J.S., Wood E. Neighborhood and HIV infection among IDU: Place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place 2007, 13(2):432-439.
35. Makkai T., McAllister I. Prevalence of tattooing and body piercing in the Australian community. Communicable Diseases Intelligence 2001, 25(2):67-72.
36. McGovern B.H., Wurcel A., Kim A.Y., Schulze zur Wiesch J., Bica I., Zaman M.T., et al. Acute hepatitis C virus infection in incarcerated injection drug users. Clinical Infectious Diseases 2006, 42(12):1663-1670.
37. O'Brien S.F., Fan W., Xi G., Yi Q.L., Goldman M., Fearon M.A., et al. Declining hepatitis C rates in first-time blood donors: Insight from surveillance and case-control risk factor studies. Transfusion 2008, 48(5):902-909.
38. Perez C.M., Suarez E., Torres E.A., Roman K., Colon V. Seroprevalence of hepatitis C virus and associated risk behaviours: A population-based study in San Juan, Puerto Rico. International Journal of Epidemiology 2005, 34(3):593-599.
39. Rhodes T., Singer M., Bourgois P., Friedman S.R., Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science & Medicine 2005, 61(5):1026-1044.
40. Rotily M., Delorme C., Obadia Y., Escaffre N., Galinier-Pujol A. Survey of French prison found that injecting drug use and tattooing occurred. BMJ 1998, 316(7133):777.
41. Roy E., Haley N., Leclerc P., Boivin J.F., Cedras L., Vincelette J. Risk factors for hepatitis C virus infection among street youths. Canadian Medical Association Journal 2001, 165(5):557-560.
42. Sampson R., Raudenbush S. Systematic social observation of public spaces: A new look at disorder in urban neighborhoods. American Journal of Sociology 1999, 105(3):603-651.
43. Savoie, J., Bédard, F., & Collins, K., 2006. Neighbourhood characteristics and the distribution of crime on the Island of Montréal. Crime and justice research paper series. Statistics Canada Catalogue no. 85-561-MIE. No. 7. Ottawa.
44. Scheinmann R., Hagan H., Lelutiu-Weinberger C., Stern R., Des Jarlais D.C., Flom P.L., et al. Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence 2007, 89(1):1-12.
45. Tyndall M.W., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M.V., et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003, 17(6):887-893.
46. van Haastrecht H.J., Bax J.S., van den Hoek A.A. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons. Addiction 1998, 93(9):1417-1425.
47. Wallace R., Wallace D. Community marginalisation and the diffusion of disease and disorder in the United States. British Medical Journal 1997, 314:1341-1345.
48. Zou S., Forrester L., Giulivi A. Hepatitis C update. Canadian Journal of Public Health 2003, 94(2):127-129.